Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
701 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy France 65
702 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Germany 75
703 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 57
704 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 72
705 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 32
706 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Bulgaria 63
707 Apheresis Allogeneic Myelofibrosis hematology 2026 Standard Therapy Hungary 52
708 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Germany 64
709 Apheresis Allogeneic Non-Hodgkin Lymphoma hematology 2026 Standard Therapy Poland 24
710 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 59
711 Apheresis Allogeneic Non-Hodgkin Lymphoma hematology 2026 Standard Therapy Belgium 65
712 Apheresis Allogeneic Chronic Myelomonocytic Leukemia hematology 2026 Standard Therapy USA 65
713 Apheresis Allogeneic Acute Lymphoblastic Leukemia hematology 2026 Standard Therapy USA 47
714 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Sweden 21
715 Apheresis Autologous Multiple Myeloma hematology 2026 Standard Therapy Portugal 57
716 Apheresis Autologous Multiple Myeloma hematology 2026 Standard Therapy Portugal 68
717 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2026 Standard therapy Germany 69
718 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard therapy Germany 59
719 Apheresis Autologous Hodgkin Lymphoma Hematology 2026 Standard therapy Germany 40
720 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard therapy Germany 61
721 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard therapy Germany 46
722 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2026 Standard therapy Germany 66
723 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard therapy Germany 64
724 Apheresis Allogeneic Myeloid Sarcoma Hematology 2026 Standard therapy Germany 57
725 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard therapy Germany 38
726 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard therapy Germany 69
727 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Germany 52
728 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2026 Standard therapy USA 22
729 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard therapy USA 70
730 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Argentina 35
731 Apheresis Allogeneic Adenosine Deaminase 2 (ADA2) Deficiency Hematology 2026 Standard therapy Germany 23
732 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy USA 41
733 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2026 Standard therapy Poland 67
734 Apheresis Allogeneic Anaplastic Lymphoma Hematology 2026 Standard therapy Portugal 58
735 Apheresis Allogeneic Thalassemia Major Hematology 2026 Standard therapy India 3
736 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard therapy Poland 58
737 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy France 22
738 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Germany 50
739 Apheresis Allogeneic Myelofibrosis Hematology 2026 Standard therapy Canada 61
740 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy Poland 9
741 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard therapy Germany 48
742 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Poland 56
743 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy USA 67
744 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy United Kingdom 46
745 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Russian Federation 28
746 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard therapy Germany 51
747 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Australia 67
748 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard therapy USA 51
749 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy USA 34
750 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Lithuania 37
751 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Canada 72
752 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard therapy Germany 61
753 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard therapy Germany 65
754 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2026 Standard therapy United Kingdom 19
755 Apheresis Allogeneic T-cell Prolymphocytic Leukemia Hematology 2026 Standard therapy USA 46
756 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Canada 70
757 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy Chile 9
758 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy Belarus 17
759 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy USA 61
760 Apheresis Allogeneic Myelofibrosis Hematology 2026 Standard therapy Poland 61
761 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard therapy Spain 59
762 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard therapy Germany 64
763 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2026 Standard therapy USA 39
764 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Poland 64
765 Cord Tissue Allogeneic – Related Chronic renal disease Endocrinology 2025 Experimental Therapy Romania 50
766 Cord Tissue Allogeneic – Related Autism Neurology 2025 Experimental Therapy Romania 6
767 Cord Tissue Autologous Autism Neurology 2025 Experimental Therapy Romania 6
768 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 57,2
769 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,1
770 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3,4
771 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 2,8
772 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,9
773 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 11,9
774 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 54,2
775 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 78,4
776 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
777 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 58,2
778 Cord Tissue Autologous Autism Neurology 2025 Experimental Therapy Romania 5
779 Cord Tissue Allogeneic – Related Autism Neurology 2025 Experimental Therapy Romania 5
780 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 4,1
781 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7,9
782 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,8
783 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 25,8
784 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
785 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 62,3
786 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2025 Experimental Therapy Poland 67,2
787 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,8
788 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 61,9
789 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,11
790 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
791 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,5
792 Cord Tissue Allogeneic – Unrelated Myelitis Neurology 2025 Experimental Therapy Poland 38,8
793 Cord Tissue Allogeneic – Unrelated Anemia Neurology 2025 Experimental Therapy Poland 3,2
794 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6,8
795 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7,1
796 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2025 Experimental Therapy Poland 5,1
797 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,2
798 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1,1
799 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5,11
800 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 63